September 2026 Regulatory Activity: Increased Scrutiny and Modernisation Efforts Globally

The global dietary supplement industry continues to operate within an evolving regulatory landscape, as evidenced by a series of actions from key agencies in September 2026. These activities collectively underscore efforts to enhance product safety, ensure accurate labelling, and modernise oversight frameworks. ## Regulatory Actions and Modernisation Initiatives September 2026 was characterised by active regulatory enforcement. The US Food and Drug Administration (FDA) issued six recalls pertaining to dietary supplements. Concurrently, the European Food Safety Authority (EFSA) published four novel food opinions, reflecting its role in assessing the safety of new ingredients for the EU market. In Canada, Health Canada also initiated a product recall, specifically citing labelling issues. These actions collectively demonstrate ongoing regulatory vigilance across major markets. Beyond immediate enforcement, the FDA is engaged in discussions regarding the modernisation of dietary supplement oversight. The Office of Dietary Supplement Programs is reportedly committed to ensuring public safety, with industry stakeholders participating in discussions to outline priorities for this modernisation. Key areas of discussion include maintaining product safety and ensuring proper labelling (nutraingredients.com). ## Evolving US and European Frameworks The US regulatory environment for supplements is undergoing significant evolution. Discussions in 2026 have included federal and state measures shaping supplement oversight, touching upon topics such as product listing requirements, drug preclusion, and federal pre-emption (nutritionaloutlook.com). A notable proposal from the FDA is a mandatory notification requirement for Generally Recognized As Safe (GRAS) substances, which carries considerable legal and commercial implications for manufacturers (nutritionaloutlook.com). In Europe, a trend towards tighter regional regulations is emerging. The Netherlands, for example, is proposing stricter controls on certain botanicals used in supplements (nutraingredients.com). This development suggests that while broader EU regulations provide a baseline, individual member states may introduce additional, more stringent requirements, potentially creating further complexity for pan-European market access. ## Industry Implications Ongoing regulatory activities signal a continued focus on transparency, product safety, and consumer protection. For manufacturers, formulators, and brand owners, staying informed of these developments is critical for maintaining compliance and market access. The proposed changes, particularly in the US with GRAS notification and discussions around product listing, could necessitate adjustments to product development, ingredient sourcing, and labelling practices. Similarly, regional variations in Europe, such as the proposed Dutch botanical restrictions, highlight the need for granular, market-specific regulatory intelligence.